Matthias Eder

Active 1966–2025

155
Papers
22,526
Citations
77
h-index
125
i10-index

Citations

Citations per year for Matthias Eder1978: 1 citations1983: 1 citations1984: 3 citations1988: 1 citations1990: 2 citations1991: 6 citations1992: 20 citations1993: 10 citations1994: 14 citations1995: 75 citations1996: 39 citations1997: 31 citations1998: 28 citations1999: 15 citations2000: 13 citations2001: 12 citations2002: 19 citations2003: 38 citations2004: 61 citations2005: 69 citations2006: 78 citations2007: 131 citations2008: 139 citations2009: 133 citations2010: 148 citations2011: 155 citations2012: 170 citations2013: 155 citations2014: 190 citations2015: 298 citations2016: 438 citations2017: 403 citations2018: 348 citations2019: 1,082 citations2020: 911 citations2021: 992 citations2022: 594 citations2023: 429 citations2024: 794 citations2025: 331 citations2026: 5 citations1979–1982: no citations, so these years are not shown1985–1987: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,269 citing papers, 23% of this breakdownGermany: 1,273 citing papers, 12.9% of this breakdownChina: 853 citing papers, 8.6% of this breakdownItaly: 530 citing papers, 5.4% of this breakdownUnited Kingdom: 454 citing papers, 4.6% of this breakdownFrance: 384 citing papers, 3.9% of this breakdownCanada: 329 citing papers, 3.3% of this breakdownSpain: 319 citing papers, 3.2% of this breakdownAustralia: 292 citing papers, 3% of this breakdownSwitzerland: 288 citing papers, 2.9% of this breakdownNetherlands: 276 citing papers, 2.8% of this breakdownJapan: 254 citing papers, 2.6% of this breakdown
0%23%Other 23.8%

Fields

  • Medicine59.2%
  • Biochemistry, Genetics and Molecular Biology21.3%
  • Neuroscience11%
  • Engineering1.8%
  • Immunology and Microbiology1.7%
  • Computer Science1%
  • Other4%

Topics

  • Prostate Cancer Treatment and Research7.1%
  • Radiopharmaceutical Chemistry and Applications7.1%
  • Prostate Cancer Diagnosis and Treatment3.6%
  • Neuroscience and Neuropharmacology Research3.4%
  • Cannabis and Cannabinoid Research3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms2.1%
  • Other73.3%

Coauthors

All papers

Open in search
  1. [177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer

    Authors: , - Pharmaceuticals 2022 cited by 286

  2. The Role of m6A/m-RNA Methylation in Stress Response Regulation

    Authors: , , , , , , , , , , , , , , , , , , , - Neuron 2018 cited by 418

  3. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 621

  4. 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

    Authors: , , , , , , , - Bioconjugate Chemistry 2012 cited by 841

  5. Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain

    Authors: , , , , , , , , , - Nature Methods 2007 cited by 1,270

  6. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

    Authors: , , , , , , , , - Journal of Nuclear Medicine 2015 cited by 594

  7. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hartmut Döhner, Arnold Ganser, Michael Heuser - Blood 2018 cited by 301

  8. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2015 cited by 426

  9. [68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer

    Authors: , - Pharmaceuticals 2021 cited by 167

  10. CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

    Authors: , , , , , , , , , , , , , , , , - Science 2003 cited by 1,212

  11. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

    Authors: , , , , , , , , , , , , , - Nature Medicine 2006 cited by 1,105

  12. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

    Authors: , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2012 cited by 924

  13. Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

    Authors: , , , , , , , - Journal of Medicinal Chemistry 2016 cited by 222

  14. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

    Authors: , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2014 cited by 974

  15. Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alon Chen - Neuron 2022 cited by 77

  16. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

    Authors: , , , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2017 cited by 515

  17. Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans

    Authors: , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2014 cited by 177

  18. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Hematology 2019 cited by 99

  19. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

    Authors: , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2013 cited by 928

  20. The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2006 cited by 710

  21. Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1

    Authors: , , , , , , , , , , , , , , , , , , , - Science 2011 cited by 322

  22. Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 258

  23. The co-chaperone Fkbp5 shapes the acute stress response in the paraventricular nucleus of the hypothalamus of male mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2021 cited by 108

  24. AutoImplant 2020-First MICCAI Challenge on Automatic Cranial Implant Design

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor Alves, Ulrike Zefferer, Gord von Campe, Karin Pistracher, Ute Schäfer, Dieter Schmalstieg, Bjoern Menze, Ben Glocker, Jan Egger - IEEE Transactions on Medical Imaging, IEEE Trans. Medical Imaging 2021 cited by 54